Fatigue in MS might be caused by low antibodies – new study investigates
NCT ID NCT05357781
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether low levels of immunoglobulin G (IgG), a type of antibody, are linked to fatigue in people with multiple sclerosis (MS). Researchers will compare fatigue scores and infection rates between MS patients with low IgG and those with normal IgG. The goal is to see if low IgG is a treatable cause of fatigue, which could lead to new ways to help patients feel better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study confirms the link, it could point toward treating fatigue in MS patients with IgG replacement therapy.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks for a connection, so it may not lead to any new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Bern Inselspital
RECRUITINGBern, Canton of Bern, 3010, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?